YTHDF3 at the crossroads of the Epitranscriptome: Structure, networks, and disease roles
Cellular Signalling · 2026-01 · 137 · 112188
DOI: 10.1016/j.cellsig.2025.112188 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2026-01. Verfasst von Kai Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Cancer Center, Zhejiang Univ…. Hauptthemen laut MEDLINE: RNA Splicing Factors, Neoplasms, RNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
N6-methyladenosine (m6A) is the predominant internal RNA modification that programs RNA splicing, stability, translation, and decay through writer, eraser, and reader proteins. Among readers, YTHDF3 has emerged as a pleiotropic and context-dependent effector. It enhances translation, promotes decay, or stabilizes transcripts-often in concert with YTHDF1/2-and its activities are further tuned by liquid-liquid phase separation and post-translational modifications. Physiologically, YTHDF3 regulates stem-cell fate, neuronal plasticity, and antiviral immunity. In cancer, it exerts dual actions by reinforcing oncogenic and metabolic pathways in many settings, yet restraining tumor growth or immune evasion in others. YTHDF3 also shapes responses to targeted therapy, chemotherapy, and immunotherapy. This review synthesizes the biochemical underpinnings, network positioning, and functional spectrum of YTHDF3, and outlines opportunities for context-specific therapeutic intervention within the epitranscriptomic landscape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China.
- Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: drliuben@zju.ed…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yu, K., Sun, J., Shi, Y., Zhang, J., & Liu, B. (2026). YTHDF3 at the crossroads of the Epitranscriptome: Structure, networks, and disease roles. Cellular Signalling, 137, 112188. https://doi.org/10.1016/j.cellsig.2025.112188
Vancouver
Yu K, Sun J, Shi Y, Zhang J, Liu B. YTHDF3 at the crossroads of the Epitranscriptome: Structure, networks, and disease roles. Cellular Signalling. 2026;137:112188. doi:10.1016/j.cellsig.2025.112188
BibTeX
@article{Yu2026,
author = {Yu, Kai and Sun, Jiazhu and Shi, Yuchen and Zhang, Jiawei and Liu, Ben},
title = {YTHDF3 at the crossroads of the Epitranscriptome: Structure, networks, and disease roles},
journal = {Cellular Signalling},
year = {2026},
volume = {137},
pages = {112188},
doi = {10.1016/j.cellsig.2025.112188}
}
EUVIMED